
KCAS Bio
Olathe, KS, United States kcasbio.com
From their website, Nov 2026
Work here? Claim this listing
- GLP
About
KCAS Bio is a bioanalytical and biomarker contract research organization serving pharmaceutical, biotechnology, and emerging biopharmaceutical companies. It supports drug development from discovery through clinical development with sites in the United States and Europe, plus a partner site in Melbourne, Australia.
Services
Small Molecule Bioanalysis
GLP/GCP-compliant bioanalysis of small molecules using LC-MS/MS platforms to quantify drugs, metabolites, and biomarkers from discovery through clinical stages.
Assays & in vitro testing
LBA for Large Molecules
Ligand binding assay services for large molecules, including tailored assay development from early discovery through clinical studies.
Assays & in vitro testing
Hybrid LC-MS/MS for Large Molecules
High-sensitivity bioanalytical services for complex and emerging large molecule therapeutics using hybrid LC-MS/MS.
Assays & in vitro testing
Immunogenicity Testing
Testing to assess immune responses to therapeutic candidates.
Assays & in vitro testing
Pharmacokinetics (PK)
Bioanalytical support for pharmacokinetic studies.
Assays & in vitro testing
Pharmacodynamics (PD)
Bioanalytical support for pharmacodynamic studies.
Assays & in vitro testing
Biomarker Testing
Biomarker analysis to support drug development programs.
Assays & in vitro testing
Flow Cytometry
Flow cytometry services for bioanalysis and immune-response work.
Assays & in vitro testing
Molecular Biology
Molecular biology services supporting bioanalytical programs.
Assays & in vitro testing
Dose Formulation
Dose formulation services for development studies.
Central Lab Technology
Central laboratory technology support for bioanalytical programs.
Capabilities
- Assays and studies
- Bioanalysis · LC-MS/MS · Small molecules · Flow cytometry · Immunogenicity · PK/PD · qPCR · ELISA · Antibodies · ADCs · Ligand binding assays · ELISpot
11 more
Meso Scale Discovery · Luminex · NULISA · AlphaLISA · Hybrid LC-MS/MS · ddPCR · LC-UV-Vis/Fluorescence · ELISA Testing · ELISpot Testing · NULISA – Argo HT · Liquid Chromatography Mass Spectrometry - Scale and capacity
- Kansas City headquarters and largest site · Philadelphia site: 26,000 ft² (2,500 m²) facility · Kansas City site: 70,000 ft² (6,500 m²) · More than 315 approved drugs on the market · More than 6,200 proprietary and non-proprietary assays · More than 20 FDA audits with no major findings · 25+ FDA inspections
- Therapeutic areas
- Allergy & Immunology · Cardiovascular · Dermatology · Gastrointestinal · Infectious Diseases · Inflammation & Pain · Metabolic · Neurology & CNS · Oncology · Ophthalmology · Rare Diseases · Renal
1 more
Respiratory
Instruments and platforms
- Meso Scale Discovery
- ELISA
- ELISpot
- Luminex
- NULISA – Argo HT
- AlphaLISA
- Liquid Chromatography Mass Spectrometry
- Hybrid LC-MS/MS
- qPCR
- ddPCR
- Flow Cytometry
- LC-UV-Vis/Fluorescence
Modalities and species
- Modalities
- Small molecule · Antibody · Bispecific · ADC
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: development services
Company
- Type
- CRO
Locations
- Address
- 10830 S. Clay Blair Blvd., Olathe, KS 66061
- Sites
- Kansas City, United States · Philadelphia, United States · Lyon, France · Melbourne, Australia
- Serves
- global, United States, Europe, APAC
Similar labs
Work here? Claim this listing